FACILITATING REMOTE CONFIGURATION
    4.
    发明公开

    公开(公告)号:US20240304318A1

    公开(公告)日:2024-09-12

    申请号:US18596708

    申请日:2024-03-06

    发明人: Andre Roth

    IPC分类号: G16H40/40

    CPC分类号: G16H40/40

    摘要: A computer implemented method of a design enterprise network for facilitating remote configuration of a software instance comprised in a laboratory enterprise network, wherein the laboratory enterprise network is communicably coupled to an in vitro diagnostics (IVD) network, wherein the IVD network comprises at least one IVD instrument, and wherein the computer implemented method comprises obtaining by a generator computing instance comprised in a design enterprise network, a configuration definition input for configuring the software instance and generating, by the generator computing instance comprised in the design enterprise network, a configuration object based on the configuration definition input.

    METHOD AND SYSTEM FOR OPERATING A LABORATORY AUTOMATION SYSTEM

    公开(公告)号:US20240302393A1

    公开(公告)日:2024-09-12

    申请号:US18668368

    申请日:2024-05-20

    发明人: Michael Rein

    摘要: A method for operating a laboratory automation system, the laboratory automation system comprising a carrier comprising a reception place for receiving a sample container configured to contain a sample to be analyzed by a laboratory device; a placement device configured to pick and place the sample container; an imaging device; and a data processing device comprising at least one processor and a memory. The method comprises detecting an image of the reception place; determining whether the reception place is free for receiving the sample container and the reception place is configured to receive the sample container, by applying a machine learning algorithm for image analysis of the image of the reception place; and placing the sample container in the reception place by the placement device if the reception place is determined as free and configured to receive the sample container. Further, a laboratory automation system is disclosed.

    AN ANALYZER SYSTEM
    8.
    发明公开
    AN ANALYZER SYSTEM 审中-公开

    公开(公告)号:US20240248069A1

    公开(公告)日:2024-07-25

    申请号:US18566548

    申请日:2022-05-31

    IPC分类号: G01N30/72 G01N30/62

    CPC分类号: G01N30/7266 G01N2030/621

    摘要: An analyzer system (110) is disclosed. The analyzer system (110) comprises:



    at least one mass spectrometry device (112) having at least one electrospray ion source nozzle (114);
    at least one liquid supply (116), wherein the liquid supply (116) is configured for providing at least one liquid having at least one analyte;
    at least one gas supply (118), wherein the gas supply (118) is configured for providing at least one gas; and
    at least one dopand gas supply (120), wherein the dopand gas supply (120) is configured for providing at least one chemical dopand gas having at least one chemical dopand (122) to the analyte provided by the liquid supply (116);

    wherein the liquid supply (116) and the gas supply (118) are coupled to the mass spectrometry device (112) via the electrospray ion source nozzle (114), wherein the dopand gas supply (120) is connected to the gas supply (118).

    STREM1 MARKER PANELS FOR EARLY DETECTION OF SEPSIS

    公开(公告)号:US20240230674A1

    公开(公告)日:2024-07-11

    申请号:US18558119

    申请日:2022-04-29

    IPC分类号: G01N33/68 G16H50/20

    摘要: The present invention concerns the field of diagnostics. Specifically, it relates to a method for assessing a subject with suspected infection comprising the steps of determining the amount of a first biomarker in a sample of the subject, said first biomarker being STREM1, determining the amount of a second biomarker in a sample of the subject, wherein said second biomarker is selected from the group consisting of: Aspartate aminotransferase, Bilirubin, ESM-1, HBP (Heparin-binding protein), a cardiac Troponin, Alanine aminotransferase, and IL6, comparing the amounts of the biomarkers to references for said biomarkers and/or calculating a score for assessing the subject with suspected infection based on the amounts of the biomarkers, and assessing said subject based on the comparison and/or the calculation. The invention also relates to the use of a first biomarker being STREM1 and a second biomarker selected from the group consisting of: Aspartate aminotransferase, Bilirubin, ESM-1, HBP (Heparin-binding protein), a cardiac Troponin, Alanine aminotransferase, and IL6 or a detection agent specifically binding to said first biomarker and a detection agent specifically binding to said second biomarker for assessing a subject with suspected infection. Moreover, the invention further relates to a computer-implemented method for assessing a subject with suspected infection and a device and a kit for assessing a subject with suspected infection.